Tivozanib confers long-term PFS benefit in advanced renal cell carcinoma - Healio

Retrieved on: 2022-11-10 02:40:41

Tags for this article:

Click the tags to see associated articles and topics

Tivozanib confers long-term PFS benefit in advanced renal cell carcinoma - Healio. View article details on hiswai:

Excerpt

Tivozanib improved long-term PFS compared with sorafenib among patients with ... up to 4 years after initiation of their assigned study treatment.

Article found on: www.healio.com